Comparative Pharmacology
Head-to-head clinical analysis: PEG 3350 AND ELECTROLYTES versus PLENVU.
Head-to-head clinical analysis: PEG 3350 AND ELECTROLYTES versus PLENVU.
PEG 3350 AND ELECTROLYTES vs PLENVU
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
PEG 3350 is an osmotic laxative that retains water in the bowel lumen via hydrogen bonding, increasing fecal water content and stimulating peristalsis. Electrolytes (sodium sulfate, potassium chloride, sodium bicarbonate, magnesium sulfate) prevent significant fluid and electrolyte shifts by maintaining isotonicity.
PLENVU is an osmotic laxative that induces bowel cleansing by causing water retention in the colon, leading to increased intraluminal pressure and stimulation of peristalsis. Its components (polyethylene glycol 3350, sodium ascorbate, ascorbic acid, sodium sulfate) act synergistically to produce a cathartic effect.
4 liters orally of the reconstituted solution administered as a single dose at 240 mL every 10 minutes or 1 to 1.5 L/hour until rectal effluent is clear. Alternatively, 240 mL every 10 minutes until 4 L consumed.
2 sachets (each containing ascorbic acid 4.7g, macrogol 3350 52.5g, sodium ascorbate 5.9g, sodium sulfate 3.75g) dissolved in water to a total volume of 500mL, administered orally as a split-dose regimen: first dose (2 sachets in 500mL water) at 6-9 pm on the day before colonoscopy, followed by additional 500mL of clear fluids; second dose (2 sachets in 500mL water) on the morning of colonoscopy, completed at least 2 hours before the procedure, followed by additional 500mL of clear fluids.
None Documented
None Documented
Not applicable; PEG 3350 undergoes minimal systemic absorption (<0.2%), thus no meaningful terminal half-life. Systemic half-life of absorbed fraction is <2 hours.
Not applicable (non-absorbed agent); systemic absorption is minimal, so no terminal half-life is defined.
Primarily fecal (96–98%) as unabsorbed PEG 3350; electrolytes absorbed are excreted renally (sodium, potassium) and via feces (biliary excretion negligible).
Primarily fecal (90-95%) as unabsorbed drug; renal excretion is negligible (<1%).
Category C
Category C
Osmotic Laxative
Osmotic Laxative